十年来膝关节翻修术终生风险监测:澳大利亚国家登记数据的群体水平分析
该研究基于澳大利亚骨科协会国家关节置换登记系统2007至2017年全部膝关节翻修术个体数据,结合人口数据与寿命表计算男女性终生翻修风险。2017年女性终生风险为2.22%(95%CI 2.13%至2.31%),男性为2.02%(95%CI 1.93%至2.11%),较2007年略有升高;翻修指征中松动/溶解和疼痛占比下降,感染占比上升。
要点
- 2017年女性膝关节翻修终生风险为2.22%(95%CI 2.13%至2.31%),男性为2.02%(95%CI 1.93%至2.11%)。
- 翻修指征中感染占比从2007年19%升至2017年29%,松动/溶解从41%降至24%。
- 作者认为全国登记数据可用于翻修负担的群体水平量化与持续监测。
核心结论
- 经过验证的国家登记数据有助于理解膝关节翻修术的流行病学,包括不断变化的临床指征。
- 尽管十年间略有升高,澳大利亚膝关节翻修术的终生风险仍较低,女性为四十五分之一,男性为五十分之一。
- 这些方法提供了量化翻修负担的群体水平途径,可用于持续的国家监测和国家间比较。
研究设计与样本
- 研究获取澳大利亚骨科协会国家关节置换登记系统2007至2017年澳大利亚所有膝关节翻修术的去标识个体水平数据。
- 人口数据与寿命表来自澳大利亚统计局,采用标准化公式计算每年终生翻修风险,并分别对男性和女性进行计算。
主要发现
- 研究期间澳大利亚共实施43,188例膝关节翻修术,手术中位年龄为69岁(四分位距62至76岁)。
- 2017年膝关节翻修率最高为70至79岁男性,为每10万人口102.9例。
- 女性终生翻修风险从2007年1.61%(95%CI 1.53%至1.69%)升至2017年2.22%(95%CI 2.13%至2.31%)。
- 男性终生翻修风险从2007年1.43%(95%CI 1.36%至1.51%)升至2017年2.02%(95%CI 1.93%至2.11%)。
- 因松动/溶解实施的翻修占比从2007年41%降至2017年24%,因疼痛从14%降至9%,感染从19%升至29%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: This study aimed to describe the use of revision knee arthroplasty in Australia and examine changes in lifetime risk over a decade. METHODS: De-identified individual-level data on all revision knee arthroplasties performed in Australia from 2007 to 2017 were obtained from the Australian Orthopaedic Association National Joint Replacement Registry. Population data and life tables were obtained from the Australian Bureau of Statistics. The lifetime risk of revision surgery was calculated for each year using a standardized formula. Separate calculations were undertaken for males and females. RESULTS: In total, 43,188 revision knee arthroplasty procedures were performed in Australia during the study period, with a median age at surgery of 69 years (interquartile range (IQR) 62 to 76). In 2017, revision knee arthroplasty rates were highest for males aged 70 to 79 years (102.9 procedures per 100,000 population). Lifetime risk of revision knee arthroplasty for females increased slightly from 1.61% (95% confidence interval (CI) 1.53% to 1.69%) in 2007 to 2.22% (95% CI 2.13% to 2.31%) in 2017. A similar pattern was evident for males, with a lifetime risk of 1.43% (95% CI 1.36% to 1.51%) in 2007 and 2.02% (95% CI 1.93% to 2.11%) in 2017. A decline in procedures performed for loosening/lysis (from 41% in 2007 to 24% in 2017) and pain (from 14% to 9%) was evident, while infection became an increasingly common indication (from 19% in 2007 to 29% in 2017). CONCLUSION: Well-validated national registry data can help us understand the epidemiology of revision knee arthroplasty, including changing clinical indications. Despite a small increase over a decade, the lifetime risk of revision knee arthroplasty in Australia is low at one in 45 females and one in 50 males. These methods offer a population-level approach to quantifying revision burden that can be used for ongoing national surveillance and between-country comparisons. Cite this article: Bone Joint J 2022;104-B(5):613-619.
引用
- Ackerman IN, Busija L, Lorimer M, et al. Monitoring the lifetime risk of revision knee arthroplasty over a decade : a population-level analysis of Australian national registry data. Bone Joint J. 2022. PMID: 35491580. doi:10.1302/0301-620X.104B5.BJJ-2021-1219.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。